ArticleJournal of biomedicine & biotechnology2010
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity.
Joris D Veltman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it